"Term" "Overlap" "P.value" "Adjusted.P.value" "Old.P.value" "Old.Adjusted.P.value" "Odds.Ratio" "Combined.Score" "Genes"
"1" "NOTCH1 regulation of human endothelial cell calcification WP3413" "6/17" 0.000281245652530487 0.13274794799439 0 0 6.02803034108605 49.2868763484272 "JAG1;GJA5;LPAR1;CALU;SOX6;SAT1"
"2" "VEGFA-VEGFR2 Signaling Pathway WP3888" "25/236" 0.00305097179001615 0.720029342443812 0 0 1.80926051904066 10.4797708742236 "FLT1;PRKAA2;ROCK1;SRF;PXN;NDRG1;HDAC9;SLC8A1;CAMKK2;GRB10;DNAJB9;ITGAV;MAP2K6;JAG1;FRS2;SMARCA2;PGF;VAV2;NR4A3;RPS6KB1;MAPKAPK2;BCL2;PRKD1;BCAR1;ATF4"
"3" "Regulation of Microtubule Cytoskeleton WP2038" "8/46" 0.00481524913841009 0.757599197776522 0 0 2.97033379125979 15.8496045533119 "TIAM1;TRIO;ROCK1;GNAQ;STMN1;MAPKAPK2;ABL1;PRKACA"
"4" "Apoptosis WP254" "11/84" 0.00970355155327195 1 0 0 2.2365906225855 10.3671864769026 "HRK;MAPK10;HELLS;CASP7;CASP8;IRF1;BCL2;BIRC5;PMAIP1;NFKBIE;BCL2L2"
"5" "Mesodermal Commitment Pathway WP2857" "16/147" 0.01234633928535 1 0 0 1.85898441357756 8.16911306503859 "ZNF462;SRF;ARID5B;PHF6;POU5F1;PARP8;ADAM19;SOX17;PRKAR1A;TRIM5;SESN1;HAND1;TCF4;PRKACA;TEAD1;FOXA2"
"6" "Insulin Signaling WP481" "17/160" 0.0126777841196779 0.997319017414661 0 0 1.81468830059778 7.92638446697479 "MAP3K2;PRKAA2;SRF;SNAP23;PPP1R3A;SORBS1;MAPK10;RPS6KA6;TBC1D4;RPS6KB1;KIF3A;GRB10;MAP3K9;MAP3K13;SOS1;MAP3K4;MAP2K6"
"7" "p38 MAPK Signaling Pathway WP400" "6/34" 0.0130470025133177 0.879740740897993 0 0 3.01401517054303 13.0784051762582 "MAX;MAPKAPK2;MAP3K9;MEF2D;TGFBR1;MAP2K6"
"8" "Apoptosis Modulation and Signaling WP1772" "11/91" 0.0171098879676083 1 0 0 2.06454519007892 8.39877368410477 "HRK;CASP7;CASP8;TRAF6;TOLLIP;BCL2;BIRC5;PMAIP1;PRKD1;NAIP;BCL2L2"
"9" "Adipogenesis WP236" "14/130" 0.0200721586297454 1 0 0 1.83932207843395 7.18884607985032 "RB1;NCOA2;MBNL1;EPAS1;CELF1;ADIPOQ;EBF1;LIFR;GATA2;ZMPSTE24;KLF7;SP1;NRIP1;MEF2D"
"10" "SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991" "3/11" 0.0231788579659951 1 0 0 4.65802344538467 17.5351977813542 "CCND2;SRF;MEF2D"
"11" "Lipid Metabolism Pathway WP3965" "5/29" 0.0250566781839145 1 0 0 2.94472746547307 10.8560761294883 "PRKAA2;PDHA1;PRKAR1A;ABHD5;PRKACA"
"12" "miRs in Muscle Cell Differentiation WP2012" "5/29" 0.0250566781839145 0.985562675233971 0 0 2.94472746547307 10.8560761294883 "PRKAR1A;SRF;PRKD1;PRKACA;MEF2D"
"13" "Oxidative Damage WP3941" "6/40" 0.0277064980514268 1 0 0 2.56191289496157 9.18724587516454 "MAPK10;TRAF6;C5AR1;BCL2;MAP3K9;NFKBIE"
"14" "EGF/EGFR Signaling Pathway WP437" "16/162" 0.0282862957076944 0.953652255287981 0 0 1.68685622713519 6.01427981525828 "MAP3K2;ROCK1;CRKL;PIK3C2B;VAV2;RPS6KB1;SP1;INPP5D;RASA1;STMN1;GRB10;ABL1;SOS1;MEF2D;MAP3K4;BCAR1"
"15" "Retinoblastoma Gene in Cancer WP2446" "10/87" 0.030557309958234 0.961536686685765 0 0 1.96315164364871 6.84777004325831 "RB1;TOP2A;BARD1;TFDP2;STMN1;ABL1;TTK;E2F3;CDC7;SMARCA2"
"16" "Translation Factors WP107" "7/52" 0.0310057649878885 0.914670067142711 0 0 2.29915259804244 7.98629536590972 "EIF4A2;EEF1B2;EIF2B3;EEF2K;EIF3J;EIF4EBP2;EIF4B"
"17" "IL-2 Signaling Pathway WP49" "6/42" 0.0343330012940796 0.953245682988562 0 0 2.43991704282054 8.22654202882421 "CCND2;RPS6KB1;IL2RA;BCL2;SOS1;CRKL"
"18" "Pathways Affected in Adenoid Cystic Carcinoma WP3651" "8/65" 0.0353141891890449 0.926016516512733 0 0 2.10208237535308 7.02825027556214 "SRCAP;MAX;CHEK2;KAT6A;KMT2C;ARID5B;IL17RD;SMARCA2"
"19" "Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814" "3/13" 0.036823463487791 0.914772356117755 0 0 3.94140445378703 13.0130199390692 "NRIP1;PGR;ESR1"
"20" "Purine metabolism WP4224" "3/13" 0.036823463487791 0.869033738311867 0 0 3.94140445378703 13.0130199390692 "PRPS1;ADSL;XDH"
"21" "Androgen receptor signaling pathway WP138" "10/90" 0.0374228221651831 0.841122479141259 0 0 1.89771325552709 6.234888589712 "RB1;PIAS4;NCOA2;ROCK1;ZMIZ1;SP1;BAG1;UBE3A;KAT7;PIAS2"
"22" "Myometrial Relaxation and Contraction Pathways WP289" "15/156" 0.0403203367855578 0.865054498308331 0 0 1.6422518557446 5.27310533803701 "RYR2;IGFBP5;LPAR1;ADCY3;SLC8A1;PRKAR1A;SP1;GNG4;GNAQ;PDE4B;PRKD1;NOS1;PRKACA;YWHAG;ATF4"
"23" "Hedgehog Signaling Pathway WP4249" "6/44" 0.0419035411887646 0.859933540917255 0 0 2.32901172269234 7.3885217150383 "CCND2;KIF3A;BCL2;PRKACA;GLI3;CSNK1G1"
"24" "Estrogen signaling pathway WP712" "4/23" 0.0424981185211369 0.835796330915692 0 0 2.97033379125979 9.38119176956926 "SP1;BCL2;PRKACA;ESR1"
"25" "H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969" "3/14" 0.0448779469093349 0.847295637648242 0 0 3.65987556423082 11.3595538552191 "RB1;JAG1;PMAIP1"
"26" "G Protein Signaling Pathways WP35" "10/93" 0.0452868066170637 0.822129720125156 0 0 1.83649669889718 5.68347893734707 "GNA13;AKAP11;PRKAR1A;GNG4;GNAQ;PDE4B;ADCY3;PRKD1;PRKACA;AKAP2"
"27" "Signaling of Hepatocyte Growth Factor Receptor WP313" "5/34" 0.0462596297039666 0.808686860010082 0 0 2.51167930878585 7.71961025488739 "RASA1;PXN;SOS1;MET;CRKL"
"28" "AMP-activated Protein Kinase (AMPK) Signaling WP1403" "8/69" 0.0478195717880444 0.806101352998464 0 0 1.98022252750653 6.0205106927649 "EEF2K;PRKAA2;PFKFB3;RPS6KB1;ADIPOQ;HMGCR;PPARGC1B;CAMKK2"
"29" "Cell Cycle WP179" "12/120" 0.0485831632332314 0.790732863658111 0 0 1.70794192997438 5.16563320858849 "RB1;STAG1;CCND2;TFDP2;CHEK2;ABL1;CDC7;TTK;E2F3;CDC6;YWHAG;CDC14B"
"30" "miRNA regulation of p53 pathway in prostate cancer WP3982" "4/24" 0.0487161625222986 0.766467623684164 0 0 2.84656988329063 8.6016066741969 "CASP8;ZMAT3;CHEK2;PMAIP1"
"31" "Cholesterol Biosynthesis Pathway WP197" "3/15" 0.053725684284932 0.818016870402836 0 0 3.41588385994876 9.98758018694491 "MSMO1;HMGCR;LSS"
"32" "Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813" "3/15" 0.053725684284932 0.792453843202747 0 0 3.41588385994876 9.98758018694491 "ZEB2;NRG3;ERBB4"
"33" "Calcium Regulation in the Cardiac Cell WP536" "14/149" 0.0544612907948009 0.778961492580183 0 0 1.60477765232492 4.67032837927629 "CHRM2;RYR2;ADCY3;ATP2B3;CACNA1C;ATP1B1;SLC8A1;PRKAR1A;GNG4;GJA5;GNAQ;PRKD1;PRKACA;YWHAG"
"34" "Viral Acute Myocarditis WP4298" "9/84" 0.0567593599194479 0.787953467117042 0 0 1.82993778211541 5.24997200875786 "CASP7;CASP8;RASA1;ABL1;BCL2;CAAP1;NOS1;SOS1;CCR3"
"35" "Target Of Rapamycin (TOR) Signaling WP1471" "5/36" 0.0570128463675223 0.768858956727729 0 0 2.37214156940886 6.79494890803652 "PRKAA2;RPS6KB1;RRAGD;PRR5L;HMGCR"
"36" "Cerebral Organic Acidurias, including diseases WP4519" "2/7" 0.0590878134724221 0.774706887749534 0 0 4.87983408564109 13.8037358919257 "L2HGDH;ALDH7A1"
"37" "Integrated Breast Cancer Pathway WP1984" "14/151" 0.0595878019119892 0.760147094661051 0 0 1.58352231918155 4.46601495124399 "RB1;BARD1;MAX;HMGCR;ESR1;TGFBR1;CASP8;ZMIZ1;SP1;CHEK2;TPR;ABL1;BCL2;MAP3K13"
"38" "RIG-I-like Receptor Signaling WP3865" "7/60" 0.0601833778948793 0.747540904378501 0 0 1.99259891830344 5.59991846185008 "MAPK10;CASP8;RNF125;SNW1;TRAF6;DHX58;TMEM173"
"39" "Photodynamic therapy-induced HIF-1 survival signaling WP3614" "5/37" 0.0628824374113908 0.761038729696832 0 0 2.30802963510051 6.38513714014044 "PDHA1;PMAIP1;BIRC5;HIF1AN;HK1"
"40" "IL-3 Signaling Pathway WP286" "6/49" 0.0651250623556532 0.768475735796708 0 0 2.09135746527475 5.71242960964664 "INPP5D;BCL2;PRKACA;SOS1;CCR3;CRKL"
"41" "mRNA Processing WP411" "12/126" 0.0656546250789617 0.75582885456756 0 0 1.62661136188036 4.42982754692279 "TMED10;HNRNPK;CLP1;CELF1;NCBP2;CPSF3;PAPOLA;HNRNPR;SRSF4;SF3B1;SRSF10;PTBP2"
"42" "Sphingolipid pathway WP1422" "4/27" 0.0701871175002434 0.788769510955116 0 0 2.53028434070279 6.72192933215217 "CERS5;SGMS2;KDSR;B4GALT6"
"43" "Integrin-mediated Cell Adhesion WP185" "10/101" 0.0714774328113505 0.784589495045521 0 0 1.69103161383602 4.46157300457139 "MAPK10;ROCK1;PXN;ITGAV;SORBS1;ARHGEF7;SOS1;BCAR1;MAP2K6;VAV2"
"44" "G13 Signaling Pathway WP524" "5/39" 0.0756002643251915 0.810984653670236 0 0 2.1896691409928 5.65437276804352 "GNA13;MAPK10;ROCK1;RPS6KB1;MAP3K4"
"45" "PDGF Pathway WP2526" "5/39" 0.0756002643251915 0.792962772477565 0 0 2.1896691409928 5.65437276804352 "TIAM1;SRF;RASA1;SOS1;VAV2"
"46" "Effects of Nitric Oxide WP1995" "2/8" 0.0757920008750839 0.777691835066078 0 0 4.26985482493595 11.0152114485691 "NOS1;XDH"
"47" "Insulin signalling in human adipocytes (diabetic condition) WP3635" "2/8" 0.0757920008750839 0.761145200277438 0 0 4.26985482493595 11.0152114485691 "TBC1D4;RPS6KB1"
"48" "Insulin signalling in human adipocytes (normal condition) WP3634" "2/8" 0.0757920008750839 0.745288008604991 0 0 4.26985482493595 11.0152114485691 "TBC1D4;RPS6KB1"
"49" "Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706" "14/158" 0.0800564460452253 0.771155970068293 0 0 1.51336626706591 3.82128511232647 "CHRM2;RYR2;CDCA7L;MBD1;GATA2;HDAC9;POU5F1;PRKAR1A;SP1;PKNOX1;PRKACA;ALDOA;PPARGC1B;YWHAG"
"50" "Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932" "24/303" 0.0821378492392608 0.775381296818622 0 0 1.35282529106882 3.38119248827726 "CHRM2;PFKFB3;FLT1;PRKAA2;EPAS1;LPAR1;PPP2R5C;PGF;EPOR;RAB11B;PIK3C2B;GHR;RPS6KB1;GNG4;PDGFD;IL2RA;COL5A2;ITGAV;NOS1;EIF4E2;SOS1;MET;EIF4B;ATF4"
"51" "TGF-beta Signaling Pathway WP366" "12/132" 0.0862442835152875 0.798182388612072 0 0 1.55267448179489 3.8049398390665 "ZEB2;SNW1;ROCK1;SP1;TRAF6;SNIP1;SOS1;MET;PIAS2;TGFBR1;BCAR1;MAP2K6"
"52" "MAPK Cascade WP422" "4/29" 0.0867715347226775 0.787618545944303 0 0 2.35578197237846 5.75865402887768 "MAP3K2;MAPK10;RASA3;MAP2K6"
"53" "Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864" "6/53" 0.0881841344905921 0.785337952444518 0 0 1.93351916600873 4.6952191415993 "HELLS;CASP7;RPS6KB1;SERBP1;ABL1;BIRC5"
"54" "Phosphodiesterases in neuronal function WP4222" "6/53" 0.0881841344905921 0.770794657028879 0 0 1.93351916600873 4.6952191415993 "GUCY1A2;PDE11A;PDE10A;PDE4B;ADCY3;NOS1"
"55" "Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680" "7/66" 0.0903818328978411 0.775640456868745 0 0 1.81145356209404 4.35421265613316 "ACTR2;FZD3;DAAM1;ERBB4;NOS1;SOS1;PFN2"
"56" "Tgif disruption of Shh signaling WP3674" "2/9" 0.0937662201481286 0.790315284105656 0 0 3.79542651105418 8.9835871114284 "TGIF2;GLI3"
"57" "Apoptosis Modulation by HSP70 WP384" "3/19" 0.0964099289962493 0.798341868179468 0 0 2.69675041574902 6.30809317663666 "MAPK10;CASP7;CASP8"
"58" "Nucleotide Metabolism WP404" "3/19" 0.0964099289962493 0.784577353210857 0 0 2.69675041574902 6.30809317663666 "PRPS1;ADSL;SAT1"
"59" "TP53 Network WP1742" "3/19" 0.0964099289962493 0.771279431969995 0 0 2.69675041574902 6.30809317663666 "BCL2;ABL1;PMAIP1"
"60" "Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation WP314" "5/42" 0.0970688934206979 0.763608628242823 0 0 2.03326420235045 4.74225186273506 "RB1;CASP7;CASP8;MAPKAPK2;BCL2"
"61" "DNA Damage Response WP707" "7/68" 0.102041352106981 0.789565872040906 0 0 1.7581755161501 4.01281959745146 "RB1;CASP8;CCND2;CHEK2;SESN1;ABL1;PMAIP1"
"62" "RAC1/PAK1/p38/MMP2 Pathway WP3303" "7/68" 0.102041352106981 0.776830938620891 0 0 1.7581755161501 4.01281959745146 "CASP7;RASA1;STMN1;PXN;BIRC5;NOS1;SOS1"
"63" "Sterol Regulatory Element-Binding Proteins (SREBP) signalling WP1982" "7/69" 0.108163168603595 0.810365326680903 0 0 1.73269471156821 3.85371120958583 "PRKAA2;SP1;HMGCR;PRKACA;SEC24D;LSS;PPARGC1B"
"64" "Nanomaterial induced apoptosis WP2507" "3/20" 0.108712761700512 0.801756617541274 0 0 2.56191289496157 5.68500278940454 "CASP7;CASP8;BCL2"
"65" "Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732" "3/20" 0.108712761700512 0.789421900348331 0 0 2.56191289496157 5.68500278940454 "SRF;GNAQ;MAPKAPK2"
"66" "Interleukin-1 Induced Activation of NF-kappa-B WP3656" "2/10" 0.112804771959913 0.806725035834527 0 0 3.41588385994876 7.45378868045718 "TRAF6;AJUBA"
"67" "Integrated Cancer Pathway WP1971" "5/44" 0.112910312583518 0.795427873722692 0 0 1.94084310224361 4.23329219269228 "RB1;BARD1;CASP8;CHEK2;BCL2"
"68" "B Cell Receptor Signaling Pathway WP23" "9/97" 0.11448090177319 0.794632141719792 0 0 1.58468838863602 3.43457004758748 "MAX;INPP5D;E2F3;SOS1;ILF2;MEF2D;CRKL;MAP2K6;VAV2"
"69" "Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817" "4/32" 0.11481351620958 0.785391009433646 0 0 2.13492741246798 4.62093523699805 "ERBB4;TNFSF11;PGR;ESR1"
"70" "Pathways Regulating Hippo Signaling WP4540" "9/98" 0.119915337106665 0.808571987347801 0 0 1.56851809895606 3.32677874898382 "FLT1;PRKAA2;PRKAR1A;GNAQ;CDH11;PRKACA;TEAD1;MET;CDH7"
"71" "miRNA Regulation of DNA Damage Response WP1530" "7/71" 0.120978296173071 0.804250081601263 0 0 1.6838864098339 3.55661077918543 "RB1;CASP8;CCND2;CHEK2;SESN1;ABL1;PMAIP1"
"72" "Kit receptor signaling pathway WP304" "6/59" 0.129981330509437 0.852099833339646 0 0 1.73689009827903 3.54388881061622 "RPS6KB1;INPP5D;GRB10;BCL2;SOS1;CRKL"
"73" "Prader-Willi and Angelman Syndrome WP3998" "6/61" 0.145702723356134 0.94207788252185 0 0 1.67994288194201 3.23588392897908 "RB1;CCND2;UBE3A;MDM4;NIPA2;CDC6"
"74" "Photodynamic therapy-induced NF-kB survival signaling WP3617" "4/35" 0.146267861338791 0.93295176421499 0 0 1.95193363425644 3.75223261488846 "TRAF6;MMP3;BIRC5;BCL2L2"
"75" "MAPK  and NFkB Signalling Pathways Inhibited by Yersinia YopJ WP3849" "2/12" 0.153348969264515 0.965076179904683 0 0 2.84656988329063 5.33742986023859 "TRAF6;MAP2K6"
"76" "Prolactin Signaling Pathway WP2037" "7/76" 0.156192539751101 0.970037878454206 0 0 1.57310440918693 2.92072916201964 "RPS6KB1;IRF1;PXN;SOS1;PPIA;YWHAG;VAV2"
"77" "Hepatitis C and Hepatocellular Carcinoma WP3646" "5/49" 0.157391596357061 0.964790045201727 0 0 1.74279788772896 3.22246524823698 "CASP7;BIRC5;SOS1;TGFBR1;VAV2"
"78" "Structural Pathway of Interleukin 1 (IL-1) WP2637" "5/49" 0.157391596357061 0.952420942058115 0 0 1.74279788772896 3.22246524823698 "MAPK10;TRAF6;TOLLIP;MAPKAPK2;MAP2K6"
"79" "ErbB Signaling Pathway WP673" "8/91" 0.163316706239178 0.975765637277114 0 0 1.50148741096649 2.72079125423079 "MAPK10;NRG3;RPS6KB1;NRG4;ERBB4;ABL1;SOS1;CRKL"
"80" "GPCRs, Other WP117" "8/91" 0.163316706239178 0.96356856681115 0 0 1.50148741096649 2.72079125423079 "CHRM2;PTGFR;GPR176;VN1R1;TAAR2;CELSR2;CELSR3;ADGRL2"
"81" "Hippo-Merlin Signaling Dysregulation WP4541" "10/120" 0.165349907144803 0.963520446572183 0 0 1.42328494164532 2.56147367082559 "LIN28B;FLT1;PRKAR1A;CDH11;ITGAV;PRKACA;AJUBA;TEAD1;MET;CDH7"
"82" "TNF alpha Signaling Pathway WP231" "8/92" 0.170354752323429 0.980578574349494 0 0 1.4851668956299 2.62855565715877 "CASP7;CASP8;RFK;OTUD7B;KSR2;SOS1;NFKBIE;MAP2K6"
"83" "Endochondral Ossification WP474" "6/64" 0.170798756611951 0.971289314708929 0 0 1.60119555935098 2.82974371922023 "GHR;KIF3A;PRKACA;SOX6;GLI3;SOX5"
"84" "Cell-type Dependent Selectivity of CCK2R Signaling WP3679" "2/13" 0.17453543372798 0.980722913328652 0 0 2.62760296919136 4.58681600036838 "RYR2;GNAQ"
"85" "Cell Differentiation - Index WP2029" "2/13" 0.17453543372798 0.969184996701256 0 0 2.62760296919136 4.58681600036838 "SRF;MEF2D"
"86" "Dopamine metabolism WP2436" "2/13" 0.17453543372798 0.957915403716358 0 0 2.62760296919136 4.58681600036838 "MAOB;PRKACA"
"87" "Estrogen Receptor Pathway WP2881" "2/13" 0.17453543372798 0.946904881834561 0 0 2.62760296919136 4.58681600036838 "SP1;ESR1"
"88" "Genes targeted by miRNAs in adipocytes WP1992" "2/13" 0.17453543372798 0.936144599086441 0 0 2.62760296919136 4.58681600036838 "SRF;PTBP2"
"89" "Focal Adhesion WP306" "15/198" 0.185243140632758 0.982413060434404 0 0 1.29389540149574 2.18161897771254 "FLT1;ROCK1;PXN;PGF;CRKL;VAV2;MAPK10;CCND2;PDGFD;COL5A2;BCL2;ITGAV;SOS1;MET;BCAR1"
"90" "Human Thyroid Stimulating Hormone (TSH) signaling pathway WP2032" "6/66" 0.188455273624891 0.98834321278832 0 0 1.55267448179489 2.59125002010372 "RB1;GNA13;RPS6KB1;GNAQ;ADCY3;MAP2K6"
"91" "EPO Receptor Signaling WP581" "3/26" 0.192883183097203 1 0 0 1.97070222689352 3.24312660235075 "RASA1;SOS1;EPOR"
"92" "DNA Damage Response (only ATM dependent) WP710" "9/110" 0.195262423080597 1 0 0 1.3974070336154 2.28253983258745 "MAPK10;CCND2;ABL1;BCL2;PMAIP1;PPP2R5C;SOS1;MAP3K4;PIK3C2B"
"93" "MAPK Signaling Pathway WP382" "18/246" 0.195343631203768 0.991421440087943 0 0 1.24971360729833 2.04077614712 "MAP3K2;MAX;SRF;CACNA1C;STK4;TGFBR1;CRKL;MAPK10;TRAF6;RASA1;STMN1;MAPKAPK2;PRKACA;MAP3K13;SOS1;MAP3K4;ATF4;MAP2K6"
"94" "Osteoblast Signaling WP322" "2/14" 0.196145021641209 0.984898406538837 0 0 2.43991704282054 3.97438327928428 "TNFSF11;ITGAV"
"95" "Cardiac Progenitor Differentiation WP2406" "5/53" 0.197311164211893 0.980324942189615 0 0 1.61126597167394 2.61504162318622 "LIN28B;SOX17;ISL1;POU5F1;FOXA2"
"96" "Circadian rhythm related genes WP3594" "15/201" 0.200496928664378 0.985776565933192 0 0 1.27458352983163 2.04820009780516 "TOP2A;NCOA2;PRKAA2;MTTP;ADIPOQ;UBE3A;MAPK10;PSPC1;GNAQ;NRIP1;ID4;TIMELESS;FBXL3;CLOCK;ATF4"
"97" "Endoderm Differentiation WP2853" "11/141" 0.203944354956929 0.992389026182172 0 0 1.33243696664668 2.11845231557181 "DUSP5;ZNF462;SOX17;TRIM5;WWC1;SESN1;TCF4;PHF6;POU5F1;PARP8;FOXA2"
"98" "IL-4 Signaling Pathway WP395" "5/54" 0.207795657887204 1 0 0 1.58142771293924 2.48473937465536 "RPS6KB1;INPP5D;BIRC5;SOS1;SOCS5"
"99" "Photodynamic therapy-induced unfolded protein response WP3613" "3/27" 0.208220194032416 0.992726581649497 0 0 1.89771325552709 2.97781408876257 "NARS;DNAJB9;ATF4"
"100" "IL-1 signaling pathway WP195" "5/55" 0.218456978668164 1 0 0 1.55267448179489 2.36187590683933 "MAP3K2;TRAF6;TOLLIP;MAPKAPK2;MAP2K6"
"101" "Nanoparticle-mediated activation of receptor signaling WP2643" "3/28" 0.223815523071289 1 0 0 1.82993778211541 2.73929448119041 "MAPK10;PXN;SOS1"
"102" "Pathways in clear cell renal cell carcinoma WP4018" "7/85" 0.229478095130844 1 0 0 1.40654041292008 2.07035392588102 "LDHB;FLT1;ME1;GRB10;PLOD2;ALDOA;HK1"
"103" "Neural Crest Differentiation WP2064" "8/101" 0.239252919101929 1 0 0 1.35282529106882 1.93485679183639 "FZD3;OLIG3;HAND1;TCF4;ISL1;HDAC9;CDH7;SOX5"
"104" "Cannabinoid receptor signaling WP3869" "3/29" 0.239628292236998 1 0 0 1.76683647928384 2.52421980374424 "MAPK10;PRKAR1A;PRKACA"
"105" "PDGFR-beta pathway WP3972" "3/29" 0.239628292236998 1 0 0 1.76683647928384 2.52421980374424 "SRF;RASA1;SOS1"
"106" "Cori Cycle WP1946" "2/16" 0.24015822940506 1 0 0 2.13492741246798 3.04538275766019 "GPT;HK1"
"107" "ID signaling pathway WP53" "2/16" 0.24015822940506 1 0 0 2.13492741246798 3.04538275766019 "RB1;PAX2"
"108" "Angiopoietin Like Protein 8 Regulatory Pathway WP3915" "10/132" 0.245109583924346 1 0 0 1.29389540149574 1.81928148321044 "MAP3K2;MAPK10;RPS6KA6;PRKAA2;RPS6KB1;MAP3K9;MAP3K13;SOS1;MAP3K4;MAP2K6"
"109" "Heart Development WP1591" "4/44" 0.255821546219937 1 0 0 1.55267448179489 2.11672255672342 "SRF;HAND1;ISL1;FOXA2"
"110" "Vitamin B6-dependent and responsive disorders WP4228" "1/5" 0.260440612941638 1 0 0 3.41588385994876 4.59566325236969 "ALDH7A1"
"111" "Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678" "2/17" 0.262355145621769 1 0 0 2.00934344702868 2.68861440792758 "JAG1;EPAS1"
"112" "Canonical and Non-Canonical TGF-B signaling WP3874" "2/17" 0.262355145621769 1 0 0 2.00934344702868 2.68861440792758 "LOXL4;TGFBR1"
"113" "miR-509-3p alteration of YAP1/ECM axis WP3967" "2/17" 0.262355145621769 1 0 0 2.00934344702868 2.68861440792758 "TEAD1;BCAR1"
"114" "Glycolysis and Gluconeogenesis WP534" "4/45" 0.26894876404819 1 0 0 1.51817060442167 1.99371384115232 "LDHB;PDHA1;ALDOA;HK1"
"115" "GABA receptor Signaling WP4159" "3/31" 0.271749972523227 1 0 0 1.65284702900747 2.15344952605929 "GABRB2;GABRB1;GABRA4"
"116" "IL17 signaling pathway WP2112" "3/31" 0.271749972523227 1 0 0 1.65284702900747 2.15344952605929 "SP1;TRAF6;IL17RD"
"117" "Toll-like Receptor Signaling WP3858" "3/31" 0.271749972523227 1 0 0 1.65284702900747 2.15344952605929 "TICAM2;TOLLIP;TRAF6"
"118" "Ras Signaling WP4223" "13/184" 0.282059877916188 1 0 0 1.20669810269929 1.52724043627852 "RAB5B;FLT1;KSR2;STK4;MAPK10;TIAM1;RASA3;GNG4;RASA1;ABL1;PRKACA;SOS1;MET"
"119" "Transcription co-factors SKI and SKIL protein partners WP4533" "2/18" 0.284559699215331 1 0 0 1.89771325552709 2.3850691875115 "SATB2;TEAD1"
"120" "Leptin signaling pathway WP2034" "6/76" 0.285397305238363 1 0 0 1.34837520787451 1.69069128864573 "PRKAA2;ROCK1;RPS6KB1;SP1;SOS1;ESR1"
"121" "Constitutive Androstane Receptor Pathway WP2875" "3/32" 0.287984777616063 1 0 0 1.60119555935098 1.99324453844397 "NCOA2;SP1;NR1I3"
"122" "Ovarian Infertility Genes WP34" "3/32" 0.287984777616063 1 0 0 1.60119555935098 1.99324453844397 "CCND2;NRIP1;PGR"
"123" "Ectoderm Differentiation WP2858" "10/138" 0.289332153051269 1 0 0 1.23763907969158 1.5348951500812 "TTC14;BCAS3;PLCXD3;PTPRB;SORCS1;CELSR2;GLI3;TRIM33;RAB8B;FOXA2"
"124" "NO/cGMP/PKG mediated Neuroprotection WP4008" "4/47" 0.295528824583656 1 0 0 1.4535675999782 1.77188277234711 "GUCY1A2;BCL2;CNGA2;NOS1"
"125" "MECP2 and Associated Rett Syndrome WP3584" "5/62" 0.296957124300658 1 0 0 1.37737252417289 1.67236097245912 "SP1;TET3;UBE3A;NREP;TAF1"
"126" "Thermogenesis WP4321" "8/108" 0.298290594885997 1 0 0 1.26514217035139 1.5304261846514 "RPS6KA6;PRKAA2;RPS6KB1;ADCY3;FRS2;PRKACA;SOS1;SMARCA2"
"127" "Corticotropin-releasing hormone signaling pathway WP2355" "7/93" 0.302430414779406 1 0 0 1.28554768922803 1.53739170313419 "NCOA2;PRKAA2;SP1;GNAQ;BCL2;TCF4;FOSL2"
"128" "Metastatic brain tumor WP2249" "1/6" 0.303752581492879 1 0 0 2.84656988329063 3.39180696163252 "E2F3"
"129" "let-7 inhibition of ES cell reprogramming WP3299" "1/6" 0.303752581492879 1 0 0 2.84656988329063 3.39180696163252 "POU5F1"
"130" "Oxidative Stress WP408" "3/33" 0.304288962573988 1 0 0 1.55267448179489 1.84733715435941 "MAPK10;SP1;XDH"
"131" "Signal transduction through IL1R WP4496" "3/33" 0.304288962573988 1 0 0 1.55267448179489 1.84733715435941 "TOLLIP;TRAF6;MAP2K6"
"132" "Cell Differentiation - Index expanded WP2023" "2/19" 0.306694964982551 1 0 0 1.79783361049935 2.1248624652747 "SRF;MEF2D"
"133" "Extracellular vesicles in the crosstalk of cardiac cells WP4300" "2/19" 0.306694964982551 1 0 0 1.79783361049935 2.1248624652747 "CD63;BIRC5"
"134" "Mitochondrial Gene Expression WP391" "2/19" 0.306694964982551 1 0 0 1.79783361049935 2.1248624652747 "SP1;PPARGC1B"
"135" "Serotonin Receptor 4/6/7 and NR3C Signaling WP734" "2/19" 0.306694964982551 1 0 0 1.79783361049935 2.1248624652747 "SRF;MAPKAPK2"
"136" "Small Ligand GPCRs WP247" "2/19" 0.306694964982551 1 0 0 1.79783361049935 2.1248624652747 "PTGFR;LPAR1"
"137" "Exercise-induced Circadian Regulation WP410" "4/48" 0.308942657943004 1 0 0 1.42328494164532 1.67178991219069 "DNAJA1;BTG1;VAPA;CLOCK"
"138" "BDNF-TrkB Signaling WP3676" "3/34" 0.320629761193192 1 0 0 1.50700758527151 1.71417322566234 "EEF2K;RPS6KB1;SOS1"
"139" "Imatinib and Chronic Myeloid Leukemia WP3640" "2/20" 0.328692985042339 1 0 0 1.70794192997438 1.90030937670335 "FLT1;ABL1"
"140" "Oncostatin M Signaling Pathway WP2374" "5/65" 0.3319717340609 1 0 0 1.31380148459568 1.44873605998937 "CASP7;MMP3;PXN;LIFR;SOS1"
"141" "Photodynamic therapy-induced AP-1 survival signaling. WP3611" "4/50" 0.335924257272163 1 0 0 1.3663535439795 1.49051350191788 "RB1;TRAF6;BCL2;MAP2K6"
"142" "Synaptic signaling pathways associated with autism spectrum disorder WP4539" "4/50" 0.335924257272163 1 0 0 1.3663535439795 1.49051350191788 "PRKAA2;RPS6KB1;UBE3A;CACNA1C"
"143" "Acetylcholine Synthesis WP528" "1/7" 0.344530039548499 1 0 0 2.43991704282054 2.59991215030281 "PDHA1"
"144" "EV release from cardiac cells and their functional effects WP3297" "1/7" 0.344530039548499 1 0 0 2.43991704282054 2.59991215030281 "ERBB4"
"145" "Mevalonate pathway WP3963" "1/7" 0.344530039548499 1 0 0 2.43991704282054 2.59991215030281 "HMGCR"
"146" "MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593" "1/7" 0.344530039548499 1 0 0 2.43991704282054 2.59991215030281 "HIF1AN"
"147" "Molybdenum cofactor (Moco) biosynthesis WP4507" "1/7" 0.344530039548499 1 0 0 2.43991704282054 2.59991215030281 "XDH"
"148" "Non-homologous end joining WP438" "1/7" 0.344530039548499 1 0 0 2.43991704282054 2.59991215030281 "XRCC4"
"149" "Pentose Phosphate Metabolism WP134" "1/7" 0.344530039548499 1 0 0 2.43991704282054 2.59991215030281 "RPE"
"150" "PI3K-Akt Signaling Pathway WP4172" "22/340" 0.344748698237028 1 0 0 1.10513889586578 1.17690610549643 "CHRM2;FLT1;PRKAA2;LPAR1;PPP2R5C;PGF;EPOR;GHR;CCND2;RPS6KB1;GNG4;PDGFD;IL2RA;BCL2;COL6A3;ITGAV;COL6A6;EIF4E2;SOS1;MET;EIF4B;ATF4"
"151" "Signaling Pathways in Glioblastoma WP2261" "6/82" 0.347969294501794 1 0 0 1.24971360729833 1.3192489687248 "RB1;CCND2;MDM4;MET;PIK3C2B;MAP2K6"
"152" "Glycerophospholipid Biosynthetic Pathway WP2533" "2/21" 0.350493983903497 1 0 0 1.62661136188036 1.70535844330281 "PTPMT1;CRLS1"
"153" "Neovascularisation processes WP4331" "2/21" 0.350493983903497 1 0 0 1.62661136188036 1.70535844330281 "JAG1;TGFBR1"
"154" "Histone Modifications WP2369" "5/67" 0.355525479223151 1 0 0 1.27458352983163 1.31812121390486 "SETD5;SETD9;KMT2C;PRDM2;KMT5A"
"155" "Chemokine signaling pathway WP3929" "11/164" 0.36553153808139 1 0 0 1.14557080669013 1.15290557123984 "TIAM1;ROCK1;GNG4;PXN;CCR9;ADCY3;SOS1;CCR3;BCAR1;CRKL;VAV2"
"156" "PI3K/AKT/mTOR - VitD3 Signalling WP4141" "2/22" 0.372045644625595 1 0 0 1.55267448179489 1.53518939776361 "PRKAA2;PDHA1"
"157" "Regulation of Apoptosis by Parathyroid Hormone-related Protein WP3872" "2/22" 0.372045644625595 1 0 0 1.55267448179489 1.53518939776361 "BCL2;BCL2L2"
"158" "Transcription factor regulation in adipogenesis WP3599" "2/22" 0.372045644625595 1 0 0 1.55267448179489 1.53518939776361 "ADIPOQ;NRIP1"
"159" "miRNA targets in ECM and membrane receptors WP2911" "2/22" 0.372045644625595 1 0 0 1.55267448179489 1.53518939776361 "COL5A2;COL6A3"
"160" "FTO Obesity Variant Mechanism WP3407" "1/8" 0.382921180533453 1 0 0 2.13492741246798 2.04937255749786 "ARID5B"
"161" "Amyotrophic lateral sclerosis (ALS) WP2447" "3/38" 0.385766172753101 1 0 0 1.34837520787451 1.28435956196658 "BCL2;NOS1;MAP2K6"
"162" "Nuclear Receptors WP170" "3/38" 0.385766172753101 1 0 0 1.34837520787451 1.28435956196658 "NR1I3;PGR;ESR1"
"163" "Striated Muscle Contraction Pathway WP383" "3/38" 0.385766172753101 1 0 0 1.34837520787451 1.28435956196658 "TMOD1;TNNI1;TTN"
"164" "Interferon type I signaling pathways WP585" "4/54" 0.390015760625809 1 0 0 1.26514217035139 1.19121754602136 "RPS6KB1;EIF4B;CRKL;MAP2K6"
"165" "Hippo-Yap signaling pathway WP4537" "2/23" 0.393302441582456 1 0 0 1.4851668956299 1.3859226846241 "NDRG1;TEAD1"
"166" "Hair Follicle Development: Cytodifferentiation (Part 3 of 3) WP2840" "6/87" 0.40096626203508 1 0 0 1.17789098618923 1.07644864665148 "IGFBP5;CUX1;BCL11B;WIF1;TCF4;ADAMTS20"
"167" "Cardiac Hypertrophic Response WP2795" "4/55" 0.403471347505111 1 0 0 1.24213958543591 1.12742775088151 "PRKD1;HDAC9;TGFBR1;MAP2K6"
"168" "Pathogenic Escherichia coli infection WP2272" "4/55" 0.403471347505111 1 0 0 1.24213958543591 1.12742775088151 "ROCK1;ARPC5L;ABL1;ARHGEF2"
"169" "Nuclear Receptors Meta-Pathway WP2882" "20/319" 0.408810561712597 1 0 0 1.07080998744475 0.957843179378889 "SRGN;NCOA2;NR1I3;ABCC5;SERPINB9;SLC7A11;SLC5A10;SLC6A2;ESR1;POU5F1;EPB41L4B;SP1;B3GNT5;ADGRF4;NRIP1;ALOX5AP;PDE4B;ME1;CES3;EPHA3"
"170" "GPCRs, Class B Secretin-like WP334" "2/24" 0.414225025718237 1 0 0 1.42328494164532 1.25440636555533 "GLP2R;ADGRL2"
"171" "ATM Signaling Pathway WP2516" "3/40" 0.417832970721122 1 0 0 1.28095644748079 1.11785676928902 "CHEK2;ABL1;MDM4"
"172" "Glycogen Synthesis and Degradation WP500" "3/40" 0.417832970721122 1 0 0 1.28095644748079 1.11785676928902 "AGL;PPP2R5C;HK1"
"173" "IL-5 Signaling Pathway WP127" "3/40" 0.417832970721122 1 0 0 1.28095644748079 1.11785676928902 "RPS6KB1;BCL2;SOS1"
"174" "ATR Signaling WP3875" "1/9" 0.419065540243758 1 0 0 1.89771325552709 1.65049426067547 "RAD9B"
"175" "Cytosine methylation WP3585" "1/9" 0.419065540243758 1 0 0 1.89771325552709 1.65049426067547 "TET3"
"176" "Metabolism of Spingolipids in ER and Golgi apparatus WP4142" "1/9" 0.419065540243758 1 0 0 1.89771325552709 1.65049426067547 "GALNT1"
"177" "Methylation Pathways WP704" "1/9" 0.419065540243758 1 0 0 1.89771325552709 1.65049426067547 "MAT2B"
"178" "Thiamine metabolic pathways WP4297" "1/9" 0.419065540243758 1 0 0 1.89771325552709 1.65049426067547 "PDHA1"
"179" "Pancreatic adenocarcinoma pathway WP4263" "6/89" 0.422137822751039 1 0 0 1.15142152582543 0.993012894849836 "RB1;MAPK10;TIAM1;RPS6KB1;E2F3;TGFBR1"
"180" "Chromosomal and microsatellite instability in colorectal cancer  WP4216" "5/73" 0.426208404002271 1 0 0 1.16982323970848 0.997656658124601 "MAPK10;BCL2;BIRC5;PMAIP1;TGFBR1"
"181" "Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433" "3/41" 0.433661830473717 1 0 0 1.24971360729833 1.04412352302618 "CASP7;CASP8;NAIP"
"182" "Differentiation of white and brown adipocyte    WP2895" "2/25" 0.434779658418483 1 0 0 1.3663535439795 1.13805760354653 "ADIPOQ;PPARGC1B"
"183" "Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668" "2/25" 0.434779658418483 1 0 0 1.3663535439795 1.13805760354653 "TGFBR1;FBN1"
"184" "Common Pathways Underlying Drug Addiction WP2636" "3/42" 0.449328619333568 1 0 0 1.21995852141027 0.97596775323951 "PRKACA;GRIA3;GRIA4"
"185" "Splicing factor NOVA regulated synaptic proteins WP4148" "3/42" 0.449328619333568 1 0 0 1.21995852141027 0.97596775323951 "KCNJ6;SNW1;NCDN"
"186" "Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269" "1/10" 0.45309450197377 1 0 0 1.70794192997438 1.3521000198587 "SP1"
"187" "Leptin and adiponectin WP3934" "1/10" 0.45309450197377 1 0 0 1.70794192997438 1.3521000198587 "ADIPOQ"
"188" "Trans-sulfuration pathway WP2333" "1/10" 0.45309450197377 1 0 0 1.70794192997438 1.3521000198587 "MAT2B"
"189" "Epithelial to mesenchymal transition in colorectal cancer WP4239" "10/159" 0.454629367689891 1 0 0 1.0741773144493 0.846744725504341 "FZD3;ZEB2;JAG1;TRAF6;EIF5A2;CLDN18;SOS1;MEF2D;TGFBR1;MAP2K6"
"190" "Glucuronidation WP698" "2/26" 0.454937690120772 1 0 0 1.31380148459568 1.03474323615384 "PGM3;HK1"
"191" "IL-6 signaling pathway WP364" "3/43" 0.464816038294088 1 0 0 1.19158739300538 0.912891269529343 "RPS6KB1;IRF1;SOS1"
"192" "Brain-Derived Neurotrophic Factor (BDNF) signaling pathway WP2380" "9/144" 0.469388070723366 1 0 0 1.06746370623399 0.807349925033149 "MAP3K2;MAPK10;TIAM1;PRKAA2;RPS6KB1;TRAF6;FRS2;GRIA3;VAV2"
"193" "LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258" "6/94" 0.474492420721299 1 0 0 1.09017569998365 0.812736487362855 "FZD3;CCND2;HNRNPK;SOX17;WIF1;RYK"
"194" "Follicle Stimulating Hormone (FSH) signaling pathway WP2035" "2/27" 0.474675081237107 1 0 0 1.26514217035139 0.942688741512587 "RPS6KB1;PRKACA"
"195" "Interleukin-11 Signaling Pathway WP2332" "3/44" 0.480108311531758 1 0 0 1.16450586134617 0.854448666459068 "RPS6KB1;BCL2;BIRC5"
"196" "Gene regulatory network modelling somitogenesis  WP2854" "1/11" 0.485131772405304 1 0 0 1.55267448179489 1.12310337592765 "EPHA4"
"197" "Methionine metabolism leading to Sulphur Amino Acids and related disorders WP4292" "1/11" 0.485131772405304 1 0 0 1.55267448179489 1.12310337592765 "MAT2B"
"198" "Serotonin Transporter Activity WP1455" "1/11" 0.485131772405304 1 0 0 1.55267448179489 1.12310337592765 "NOS1"
"199" "TLR4 Signaling and Tolerance WP3851" "2/28" 0.493971961209076 1 0 0 1.21995852141027 0.860408103075674 "INPP5D;TRAF6"
"200" "Human Complement System WP2806" "6/97" 0.505254947871871 1 0 0 1.05645892575735 0.721236194101354 "ADIPOQ;C5AR1;F13A1;CD59;PRKACA;DCN"
"201" "Aryl Hydrocarbon Receptor WP2586" "3/46" 0.510051588807949 1 0 0 1.11387517172242 0.749909112079028 "RB1;NRIP1;ESR1"
"202" "Selenium Metabolism and Selenoproteins WP28" "3/46" 0.510051588807949 1 0 0 1.11387517172242 0.749909112079028 "SELENOS;SP1;SEPHS1"
"203" "Gastric Cancer Network 1 WP2361" "2/29" 0.512812223295252 1 0 0 1.17789098618923 0.786649238529476 "TOP2A;INO80D"
"204" "Statin Pathway WP430" "2/29" 0.512812223295252 1 0 0 1.17789098618923 0.786649238529476 "MTTP;HMGCR"
"205" "Alanine and aspartate metabolism WP106" "1/12" 0.515293829858929 1 0 0 1.42328494164532 0.943663532025361 "GPT"
"206" "Bile Acids synthesis and enterohepatic circulation  WP4389" "1/12" 0.515293829858929 1 0 0 1.42328494164532 0.943663532025361 "FXR1"
"207" "Nanoparticle triggered regulated necrosis WP2513" "1/12" 0.515293829858929 1 0 0 1.42328494164532 0.943663532025361 "CASP8"
"208" "Regulation of Actin Cytoskeleton WP51" "9/150" 0.518926382451713 1 0 0 1.02476515798463 0.67223902735877 "CHRM2;ENAH;GNA13;ROCK1;PXN;ARHGEF7;SOS1;BCAR1;PIK3C2B"
"209" "G1 to S cell cycle control WP45" "4/64" 0.520555341778905 1 0 0 1.06746370623399 0.696903364983039 "RB1;CCND2;TFDP2;E2F3"
"210" "Energy Metabolism WP1541" "3/47" 0.524678133203483 1 0 0 1.09017569998365 0.703130930842611 "PRKAA2;MEF2D;PPARGC1B"
"211" "Dopaminergic Neurogenesis WP2855" "2/30" 0.531183152806258 1 0 0 1.13862795331625 0.720351149072042 "LMX1A;FOXA2"
"212" "Extracellular vesicle-mediated signaling in recipient cells WP2870" "2/30" 0.531183152806258 1 0 0 1.13862795331625 0.720351149072042 "MET;TGFBR1"
"213" "Oligodendrocyte Specification and differentiation(including remyelination), leading to Myelin Components for CNS WP4304" "2/30" 0.531183152806258 1 0 0 1.13862795331625 0.720351149072042 "SOX6;SOX5"
"214" "Rett syndrome causing genes WP4312" "3/48" 0.539060490205519 1 0 0 1.06746370623399 0.659615166144009 "SATB2;TCF4;SMARCA2"
"215" "Alzheimers Disease WP2059" "5/83" 0.539536136079818 1 0 0 1.02888068070746 0.634866210366561 "CASP7;CASP8;GNAQ;NOS1;CACNA1C"
"216" "BMP2-WNT4-FOXO1 Pathway in Human Primary Endometrial Stromal Cell Differentiation WP3876" "1/13" 0.543690346267354 1 0 0 1.31380148459568 0.800598319137712 "DCN"
"217" "Development of pulmonary dendritic cells and macrophage subsets WP3892" "1/13" 0.543690346267354 1 0 0 1.31380148459568 0.800598319137712 "TCF4"
"218" "Kennedy pathway from Sphingolipids WP3933" "1/13" 0.543690346267354 1 0 0 1.31380148459568 0.800598319137712 "ETNK1"
"219" "MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301" "1/13" 0.543690346267354 1 0 0 1.31380148459568 0.800598319137712 "ITGAV"
"220" "Osteopontin Signaling WP1434" "1/13" 0.543690346267354 1 0 0 1.31380148459568 0.800598319137712 "ITGAV"
"221" "Transcriptional cascade regulating adipogenesis WP4211" "1/13" 0.543690346267354 1 0 0 1.31380148459568 0.800598319137712 "GATA2"
"222" "Vitamin B12 Disorders WP4271" "1/13" 0.543690346267354 1 0 0 1.31380148459568 0.800598319137712 "MMAA"
"223" "Non-small cell lung cancer WP4255" "4/66" 0.545127021413306 1 0 0 1.03511632119659 0.628042796533745 "RB1;E2F3;SOS1;STK4"
"224" "Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850" "2/31" 0.549075085606016 1 0 0 1.10189801933831 0.660609987462407 "IGFBP5;RPS6KB1"
"225" "Trans-sulfuration and one carbon metabolism WP2525" "2/31" 0.549075085606016 1 0 0 1.10189801933831 0.660609987462407 "AHCYL1;MAT2B"
"226" "Tumor suppressor activity of SMARCB1 WP4204" "2/31" 0.549075085606016 1 0 0 1.10189801933831 0.660609987462407 "RB1;GLI3"
"227" "Breast cancer pathway WP4262" "9/154" 0.551096191563212 1 0 0 0.998147881153859 0.594742331289184 "RB1;FZD3;RPS6KB1;SP1;TNFSF11;PGR;E2F3;SOS1;ESR1"
"228" "Wnt Signaling Pathway and Pluripotency WP399" "6/102" 0.554963379387162 1 0 0 1.00467172351434 0.591604109608556 "MAPK10;FZD3;CCND2;PRKD1;PPP2R5C;POU5F1"
"229" "Genes related to primary cilium development (based on CRISPR) WP4536" "6/103" 0.564628599808208 1 0 0 0.99491762911129 0.568682091768704 "TTC26;KIF3A;WDPCP;CPLANE1;TUBE1;LZTFL1"
"230" "Toll-like Receptor Signaling Pathway WP75" "6/103" 0.564628599808208 1 0 0 0.99491762911129 0.568682091768704 "MAPK10;TICAM2;CASP8;TOLLIP;TRAF6;MAP2K6"
"231" "Development and heterogeneity of the ILC family WP3893" "2/32" 0.566481095038766 1 0 0 1.06746370623399 0.606651975429507 "IL22;BCL11B"
"232" "Initiation of transcription and translation elongation at the HIV-1 LTR WP3414" "2/32" 0.566481095038766 1 0 0 1.06746370623399 0.606651975429507 "SP1;HDAC9"
"233" "Monoamine Transport WP727" "2/32" 0.566481095038766 1 0 0 1.06746370623399 0.606651975429507 "NOS1;SLC6A2"
"234" "White fat cell differentiation WP4149" "2/32" 0.566481095038766 1 0 0 1.06746370623399 0.606651975429507 "EBF1;GATA2"
"235" "Cysteine and methionine catabolism WP4504" "1/14" 0.570424584573453 1 0 0 1.21995852141027 0.68485337346134 "AHCYL1"
"236" "ERK Pathway in Huntington's Disease WP3853" "1/14" 0.570424584573453 1 0 0 1.21995852141027 0.68485337346134 "CASP7"
"237" "ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336" "5/86" 0.571513603569766 1 0 0 0.992989494171152 0.555544846145099 "FZD3;CCND2;SOX17;WIF1;RYK"
"238" "Nuclear Receptors in Lipid Metabolism and Toxicity WP299" "2/33" 0.583396704975349 1 0 0 1.03511632119659 0.557811629048128 "ABCD2;NR1I3"
"239" "Pregnane X Receptor pathway WP2876" "2/33" 0.583396704975349 1 0 0 1.03511632119659 0.557811629048128 "NCOA2;NRIP1"
"240" "Prion disease pathway WP3995" "2/33" 0.583396704975349 1 0 0 1.03511632119659 0.557811629048128 "EBF1;BCL2"
"241" "miRNA regulation of prostate cancer signaling pathways WP3981" "2/33" 0.583396704975349 1 0 0 1.03511632119659 0.557811629048128 "BCL2;SOS1"
"242" "Senescence and Autophagy in Cancer WP615" "6/105" 0.583650450230898 1 0 0 0.975966817128218 0.525512279593148 "RB1;LAMP1;IGFBP5;IRF1;LAMP2;BCL2"
"243" "Wnt Signaling Pathway WP363" "3/52" 0.5939840806343 1 0 0 0.985351113446758 0.513272114817298 "RYK;TCF4;CSNK1G1"
"244" "GPCRs, Class C Metabotropic glutamate, pheromone WP501" "1/15" 0.595593772965526 1 0 0 1.13862795331625 0.590032944250699 "GPRC5B"
"245" "Oxysterols derived from cholesterol WP4545" "1/15" 0.595593772965526 1 0 0 1.13862795331625 0.590032944250699 "ESR1"
"246" "Phytochemical activity on NRF2 transcriptional activation WP3" "1/15" 0.595593772965526 1 0 0 1.13862795331625 0.590032944250699 "SLC7A11"
"247" "Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240" "1/15" 0.595593772965526 1 0 0 1.13862795331625 0.590032944250699 "STAG1"
"248" "miRNAs involved in DNA damage response WP1545" "1/15" 0.595593772965526 1 0 0 1.13862795331625 0.590032944250699 "ABL1"
"249" "Type 2 papillary renal cell carcinoma WP4241" "2/34" 0.599819627108945 1 0 0 1.00467172351434 0.513514131156658 "EPAS1;CUL2"
"250" "Primary Focal Segmental Glomerulosclerosis FSGS WP2572" "4/72" 0.614649648908617 1 0 0 0.948856627763545 0.461811225044429 "JAG1;WT1;ITGAV;PAX2"
"251" "Hedgehog Signaling Pathway WP47" "1/16" 0.619289457131005 1 0 0 1.06746370623399 0.511509922108149 "GLI3"
"252" "Interactome of polycomb repressive complex 2 (PRC2)  WP2916" "1/16" 0.619289457131005 1 0 0 1.06746370623399 0.511509922108149 "ELL"
"253" "Metabolic pathway of LDL, HDL and TG, including diseases WP4522" "1/16" 0.619289457131005 1 0 0 1.06746370623399 0.511509922108149 "MTTP"
"254" "Osteoclast Signaling WP12" "1/16" 0.619289457131005 1 0 0 1.06746370623399 0.511509922108149 "TNFSF11"
"255" "SREBF and miR33 in cholesterol and lipid homeostasis WP2011" "1/16" 0.619289457131005 1 0 0 1.06746370623399 0.511509922108149 "HMGCR"
"256" "TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453" "1/16" 0.619289457131005 1 0 0 1.06746370623399 0.511509922108149 "PDHA1"
"257" "Vitamin D Receptor Pathway WP2877" "10/182" 0.627672052650545 1 0 0 0.938429631854055 0.437061831315219 "SLC37A2;SERPINB1;IGFBP5;NRIP1;BTLA;ID4;TNFSF11;MED9;ALPG;SLC8A1"
"258" "Wnt Signaling in Kidney Disease WP4150" "2/36" 0.631187771237065 1 0 0 0.948856627763545 0.436618164408793 "MAPK10;FZD3"
"259" "DNA IR-Double Strand Breaks (DSBs) and cellular response via ATM WP3959" "3/55" 0.632278047389715 1 0 0 0.931604689076935 0.427071842107993 "CHEK2;TRAF6;ABL1"
"260" "RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway WP2018" "3/55" 0.632278047389715 1 0 0 0.931604689076935 0.427071842107993 "TRAF6;TNFSF11;MAP2K6"
"261" "Arrhythmogenic Right Ventricular Cardiomyopathy WP2118" "4/74" 0.636298893507771 1 0 0 0.923211854040206 0.417371955309437 "RYR2;ITGAV;CACNA1C;SLC8A1"
"262" "ACE Inhibitor Pathway WP554" "1/17" 0.641597832395686 1 0 0 1.00467172351434 0.445866881871896 "NR3C2"
"263" "Drug Induction of Bile Acid Pathway WP2289" "1/17" 0.641597832395686 1 0 0 1.00467172351434 0.445866881871896 "NR1I3"
"264" "Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664" "1/17" 0.641597832395686 1 0 0 1.00467172351434 0.445866881871896 "TCF4"
"265" "Serotonin and anxiety WP3947" "1/17" 0.641597832395686 1 0 0 1.00467172351434 0.445866881871896 "FMR1"
"266" "Fibrin Complement Receptor 3 Signaling Pathway WP4136" "2/37" 0.646137292894126 1 0 0 0.923211854040206 0.403206564110566 "TICAM2;TRAF6"
"267" "Melatonin metabolism and effects WP3298" "2/37" 0.646137292894126 1 0 0 0.923211854040206 0.403206564110566 "TRAF6;CLOCK"
"268" "The effect of progerin on the involved genes in Hutchinson-Gilford Progeria Syndrome WP4320" "2/37" 0.646137292894126 1 0 0 0.923211854040206 0.403206564110566 "RB1;CBX5"
"269" "Type II interferon signaling (IFNG) WP619" "2/37" 0.646137292894126 1 0 0 0.923211854040206 0.403206564110566 "IRF1;GBP1"
"270" "miRNAs involvement in the immune response in sepsis WP4329" "2/37" 0.646137292894126 1 0 0 0.923211854040206 0.403206564110566 "IRF1;TRAF6"
"271" "Parkinsons Disease Pathway WP2371" "2/38" 0.660602342038417 1 0 0 0.898916805249674 0.372693802608382 "CASP7;UBE2G1"
"272" "4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879" "1/18" 0.662600055954552 1 0 0 0.948856627763545 0.390533926055024 "MAP2K6"
"273" "Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301" "1/18" 0.662600055954552 1 0 0 0.948856627763545 0.390533926055024 "RAB5B"
"274" "Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877" "1/18" 0.662600055954552 1 0 0 0.948856627763545 0.390533926055024 "TRAF6"
"275" "Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670" "1/18" 0.662600055954552 1 0 0 0.948856627763545 0.390533926055024 "LOXL4"
"276" "Preimplantation Embryo WP3527" "3/58" 0.667989153601353 1 0 0 0.883418239641921 0.356444544333789 "GATA2;POU5F1;NR3C2"
"277" "Wnt Signaling WP428" "6/115" 0.671813124273512 1 0 0 0.891100137377938 0.35445741596843 "FZD3;CCND2;SOX17;DAAM1;WIF1;RYK"
"278" "MET in type 1 papillary renal cell carcinoma WP4205" "3/59" 0.679313695850148 1 0 0 0.868445049139516 0.335803610945873 "SOS1;MET;CRKL"
"279" "Overview of nanoparticle effects WP3287" "1/19" 0.682372540992626 1 0 0 0.898916805249674 0.343547595386683 "BCL2"
"280" "Bladder Cancer WP2828" "2/40" 0.688101779135092 1 0 0 0.85397096498719 0.319230159863952 "RB1;DAPK1"
"281" "Ferroptosis WP4313" "2/40" 0.688101779135092 1 0 0 0.85397096498719 0.319230159863952 "SLC7A11;SAT1"
"282" "DNA IR-damage and cellular response via ATR WP4016" "4/80" 0.69636027045178 1 0 0 0.85397096498719 0.309041949284745 "BARD1;SP1;CHEK2;FANCA"
"283" "Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657" "1/20" 0.700987234171011 1 0 0 0.85397096498719 0.303386509817571 "BCL2"
"284" "Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206" "1/20" 0.700987234171011 1 0 0 0.85397096498719 0.303386509817571 "PDHA1"
"285" "Hypertrophy Model WP516" "1/20" 0.700987234171011 1 0 0 0.85397096498719 0.303386509817571 "NR4A3"
"286" "Urea cycle and metabolism of amino groups WP497" "1/20" 0.700987234171011 1 0 0 0.85397096498719 0.303386509817571 "OAT"
"287" "Notch Signaling Pathway WP61" "3/61" 0.7010961521479 1 0 0 0.839971440971007 0.29828245755319 "NUMBL;JAG1;SNW1"
"288" "Proteasome Degradation WP183" "3/62" 0.711556713675119 1 0 0 0.826423514503733 0.281232049762829 "PSMB5;PSMB2;RPN1"
"289" "DNA Replication WP466" "2/42" 0.713741021192623 1 0 0 0.813305680940181 0.274275220898861 "CDC7;CDC6"
"290" "TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036" "2/42" 0.713741021192623 1 0 0 0.813305680940181 0.274275220898861 "CASP7;CASP8"
"291" "Nicotine Activity on Dopaminergic Neurons WP1602" "1/21" 0.71851187613629 1 0 0 0.813305680940181 0.268856935082236 "PRKACA"
"292" "Ciliary landscape WP4352" "11/216" 0.725516502042994 1 0 0 0.869785242116583 0.27908926153743 "RB1;DYNC1I2;MKLN1;TTC26;UBE2H;WDR26;RMND5A;TBC1D4;ARMC8;MAPRE2;LZTFL1"
"293" "Eukaryotic Transcription Initiation WP405" "2/43" 0.725883689079482 1 0 0 0.794391595336921 0.254495648617953 "POLR3H;POLR2J"
"294" "Fatty Acid Biosynthesis WP357" "1/22" 0.735010247362954 1 0 0 0.776337240897446 0.239011596829497 "ECHDC1"
"295" "Methionine De Novo and Salvage Pathway WP3580" "1/22" 0.735010247362954 1 0 0 0.776337240897446 0.239011596829497 "MAT2B"
"296" "Type II diabetes mellitus WP1584" "1/22" 0.735010247362954 1 0 0 0.776337240897446 0.239011596829497 "ADIPOQ"
"297" "Vitamin D in inflammatory diseases WP4482" "1/22" 0.735010247362954 1 0 0 0.776337240897446 0.239011596829497 "MAP2K6"
"298" "ATM Signaling Network in Development and Disease  WP3878" "2/45" 0.74886148834009 1 0 0 0.759085302210836 0.219528411690885 "CHEK2;CEP63"
"299" "Notch Signaling WP268" "2/45" 0.74886148834009 1 0 0 0.759085302210836 0.219528411690885 "NUMBL;JAG1"
"300" "Prostaglandin Synthesis and Regulation WP98" "2/45" 0.74886148834009 1 0 0 0.759085302210836 0.219528411690885 "PTGFR;PPARGC1B"
"301" "Selenium Micronutrient Network WP15" "4/86" 0.748968800993028 1 0 0 0.794391595336921 0.229625206480166 "SELENOS;RFK;ALOX5AP;XDH"
"302" "EBV LMP1 signaling WP262" "1/23" 0.750542399318335 1 0 0 0.742583447814948 0.213091103659538 "TRAF6"
"303" "NRF2-ARE regulation WP4357" "1/23" 0.750542399318335 1 0 0 0.742583447814948 0.213091103659538 "SLC7A11"
"304" "Nanoparticle triggered autophagic cell death WP2509" "1/23" 0.750542399318335 1 0 0 0.742583447814948 0.213091103659538 "BCL2"
"305" "The human immune response to tuberculosis WP4197" "1/23" 0.750542399318335 1 0 0 0.742583447814948 0.213091103659538 "IRF1"
"306" "AGE/RAGE pathway WP2324" "3/66" 0.750580224231016 1 0 0 0.776337240897446 0.222737939013261 "CASP8;ROCK1;SP1"
"307" "NRF2 pathway WP2884" "7/146" 0.757975441648697 1 0 0 0.818876267795936 0.226914129033232 "ABCC5;ME1;SLC7A11;SLC5A10;CES3;SLC6A2;EPHA3"
"308" "PPAR signaling pathway WP3942" "3/67" 0.759646541426605 1 0 0 0.764750117898977 0.210231360582664 "ADIPOQ;ME1;SORBS1"
"309" "Tryptophan metabolism WP465" "2/46" 0.759716469109547 1 0 0 0.742583447814948 0.204069344127779 "MAOB;UBE3A"
"310" "Angiogenesis WP1539" "1/24" 0.76516487263667 1 0 0 0.711642470822659 0.190481033724849 "FLT1"
"311" "IL1 and megakaryocytes in obesity WP2865" "1/24" 0.76516487263667 1 0 0 0.711642470822659 0.190481033724849 "CCR3"
"312" "Triacylglyceride Synthesis WP325" "1/24" 0.76516487263667 1 0 0 0.711642470822659 0.190481033724849 "PLPP3"
"313" "Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534" "2/47" 0.770162602510128 1 0 0 0.726783799989098 0.189802216208747 "MAPK10;TEAD1"
"314" "Allograft Rejection WP2328" "4/89" 0.772519915942608 1 0 0 0.767614350550284 0.198119336694526 "IL22;CASP7;CASP8;IL2RA"
"315" "Ebola Virus Pathway on Host WP4217" "6/129" 0.773436071527347 1 0 0 0.794391595336921 0.204088940639779 "TIAM1;CD209;ITGAV;CTSB;HAVCR2;VAV2"
"316" "Glycosylation and related congenital defects. WP4521" "1/25" 0.778930901972575 1 0 0 0.683176771989752 0.170680060105443 "MAGT1"
"317" "IL-7 Signaling Pathway WP205" "1/25" 0.778930901972575 1 0 0 0.683176771989752 0.170680060105443 "IL2RA"
"318" "MTHFR deficiency WP4288" "1/25" 0.778930901972575 1 0 0 0.683176771989752 0.170680060105443 "ALDH7A1"
"319" "Physiological and Pathological Hypertrophy  of the Heart WP1528" "1/25" 0.778930901972575 1 0 0 0.683176771989752 0.170680060105443 "LIFR"
"320" "Signal Transduction of S1P Receptor WP26" "1/25" 0.778930901972575 1 0 0 0.683176771989752 0.170680060105443 "PIK3C2B"
"321" "Amino Acid metabolism WP3925" "4/91" 0.787231651428577 1 0 0 0.750743705483244 0.179602463524147 "OAT;PDHA1;MCCC1;ALDH7A1"
"322" "Wnt/beta-catenin Signaling Pathway in Leukemia WP3658" "1/26" 0.791890608980439 1 0 0 0.656900742297839 0.153275974959828 "WIF1"
"323" "Canonical  and Non-canonical Notch signaling WP3845" "1/27" 0.804091184576301 1 0 0 0.632571085175697 0.137927445729763 "JAG1"
"324" "Eicosanoid Synthesis WP167" "1/27" 0.804091184576301 1 0 0 0.632571085175697 0.137927445729763 "ALOX5AP"
"325" "Intraflagellar transport proteins binding to dynein WP4532" "1/27" 0.804091184576301 1 0 0 0.632571085175697 0.137927445729763 "DYNC1I2"
"326" "Nonalcoholic fatty liver disease WP4396" "7/155" 0.809236808421001 1 0 0 0.771328613536817 0.163262258462863 "CASP7;CASP8;PRKAA2;ADIPOQ;MLX;NDUFS1;ATF4"
"327" "Peptide GPCRs WP24" "3/74" 0.815831245451408 1 0 0 0.692408890530154 0.140938273444087 "C5AR1;CCR9;CCR3"
"328" "ESC Pluripotency Pathways WP3931" "5/116" 0.816278361545458 1 0 0 0.736181866368268 0.149444810539542 "ACTR2;FZD3;LIFR;SOS1;MAP2K6"
"329" "Copper homeostasis WP3286" "2/52" 0.816636608422703 1 0 0 0.656900742297839 0.13306251777038 "SP1;STEAP2"
"330" "One carbon metabolism and related pathways WP3940" "2/52" 0.816636608422703 1 0 0 0.656900742297839 0.13306251777038 "AHCYL1;ETNK1"
"331" "Selective expression of chemokine receptors during T-cell polarization WP4494" "1/29" 0.826390068353028 1 0 0 0.588945493094614 0.112305061524054 "CCR3"
"332" "T-Cell Receptor and Co-stimulatory Signaling WP2583" "1/29" 0.826390068353028 1 0 0 0.588945493094614 0.112305061524054 "RASA1"
"333" "Regulation of toll-like receptor signaling pathway WP1449" "6/139" 0.830222366212742 1 0 0 0.737241120852251 0.137172338447916 "MAPK10;TICAM2;CASP8;TOLLIP;TRAF6;MAP2K6"
"334" "TGF-beta Receptor Signaling WP560" "2/54" 0.832743237364445 1 0 0 0.632571085175697 0.115779436877997 "ZEB2;TGFBR1"
"335" "Inflammatory Response Pathway WP453" "1/30" 0.836569595398976 1 0 0 0.569313976658127 0.101591553481874 "IL2RA"
"336" "Matrix Metalloproteinases WP129" "1/30" 0.836569595398976 1 0 0 0.569313976658127 0.101591553481874 "MMP3"
"337" "One Carbon Metabolism WP241" "1/30" 0.836569595398976 1 0 0 0.569313976658127 0.101591553481874 "MAT2B"
"338" "PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844" "1/30" 0.836569595398976 1 0 0 0.569313976658127 0.101591553481874 "GRB10"
"339" "Ethanol effects on histone modifications WP3996" "1/31" 0.846152723954857 1 0 0 0.550949009669155 0.0920390131947963 "HDAC9"
"340" "Gastric Cancer Network 2 WP2363" "1/31" 0.846152723954857 1 0 0 0.550949009669155 0.0920390131947963 "TOP2A"
"341" "Metapathway biotransformation Phase I and II WP702" "8/183" 0.846548992824806 1 0 0 0.746641280863117 0.124380881988339 "NAA50;NAA30;GLYATL1;NAA40;GSTO2;NDST3;HS6ST2;HS6ST3"
"342" "Alpha 6 Beta 4 signaling pathway WP244" "1/33" 0.863667397711826 1 0 0 0.517558160598297 0.0758572267395658 "SOS1"
"343" "Fluoropyrimidine Activity WP1601" "1/33" 0.863667397711826 1 0 0 0.517558160598297 0.0758572267395658 "ABCC5"
"344" "Monoamine GPCRs WP58" "1/33" 0.863667397711826 1 0 0 0.517558160598297 0.0758572267395658 "CHRM2"
"345" "MicroRNAs in cardiomyocyte hypertrophy WP1544" "3/84" 0.876478422019154 1 0 0 0.609979260705136 0.0804216135601699 "ROCK1;HDAC9;MAP2K6"
"346" "TYROBP Causal Network WP3945" "2/61" 0.879516411036121 1 0 0 0.559980960647338 0.0718920667340145 "RBM47;TGFBR1"
"347" "Pyrimidine metabolism WP4022" "3/85" 0.881445361038094 1 0 0 0.602803034108605 0.0760690791018654 "ENTPD1;POLR3H;POLR2J"
"348" "Zinc homeostasis WP3529" "1/36" 0.886275346141733 1 0 0 0.474428313881772 0.0572765927654856 "SLC30A4"
"349" "Genotoxicity pathway WP4286" "2/63" 0.890471833756102 1 0 0 0.542203787293454 0.0628977031966774 "DAAM1;TRIM22"
"350" "Lung fibrosis WP3624" "2/63" 0.890471833756102 1 0 0 0.542203787293454 0.0628977031966774 "STN1;CCR3"
"351" "GPCRs, Class A Rhodopsin-like WP455" "11/257" 0.892522232472403 1 0 0 0.731025728782809 0.0831204436900273 "CHRM2;PTGFR;NPFFR1;SUCNR1;HCAR1;GPR12;OPN1MW;CCR9;GPR75;GPR37L1;CCR3"
"352" "Cytoplasmic Ribosomal Proteins WP477" "3/89" 0.899577565874299 1 0 0 0.575710762912713 0.0609274683682081 "RPS6KA6;RPS9;RPS6KB1"
"353" "T-Cell antigen Receptor (TCR)  Signaling Pathway WP69" "3/90" 0.903701840302802 1 0 0 0.569313976658127 0.0576463396910405 "TRAF6;SOS1;CRKL"
"354" "Folate Metabolism WP176" "2/66" 0.905180831079834 1 0 0 0.517558160598297 0.0515594244206485 "RFK;NOS1"
"355" "Microglia Pathogen Phagocytosis Pathway WP3937" "1/40" 0.910701816756052 1 0 0 0.426985482493595 0.0399401150767167 "VAV2"
"356" "Spinal Cord Injury WP2431" "4/118" 0.920298546745521 1 0 0 0.57896336609301 0.0480870496015743 "RB1;EPHA4;SLIT3;NOS1"
"357" "Metabolic reprogramming in colon cancer WP4290" "1/42" 0.920872267331698 1 0 0 0.406652840470091 0.0335219964429564 "PDHA1"
"358" "Parkin-Ubiquitin Proteasomal System pathway WP2359" "2/70" 0.921931537117036 1 0 0 0.487983408564109 0.0396653960894576 "CASP8;UBE2G1"
"359" "Aryl Hydrocarbon Receptor Pathway WP2873" "1/46" 0.937872306782958 1 0 0 0.371291723907474 0.0238151979863236 "CES3"
"360" "Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203" "1/47" 0.941518149406147 1 0 0 0.363391899994549 0.0218985969268707 "IL2RA"
"361" "Differentiation Pathway WP2848" "1/48" 0.94495020656962 1 0 0 0.355821235411329 0.0201476815888689 "TNFSF11"
"362" "Hematopoietic Stem Cell Differentiation WP2849" "1/55" 0.963953587974238 1 0 0 0.310534896358978 0.0114003977286086 "GATA2"
"363" "Mitochondrial complex I assembly model OXPHOS system WP4324" "1/56" 0.966069795151347 1 0 0 0.304989630352568 0.010527996727516 "NDUFS1"
"364" "Complement and Coagulation Cascades WP558" "1/58" 0.969937046130591 1 0 0 0.294472746547307 0.00898851865106764 "C5AR1"
"365" "Oxidative phosphorylation WP623" "1/60" 0.973363820813711 1 0 0 0.284656988329063 0.00768498437934927 "NDUFS1"
"366" "T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863" "1/62" 0.976400250836206 1 0 0 0.275474504834578 0.00657907042900815 "SOS1"
"367" "Endometrial cancer WP4155" "1/63" 0.977786175438177 1 0 0 0.271101893646727 0.00609010542410435 "SOS1"
"368" "Electron Transport Chain (OXPHOS system in mitochondria) WP111" "2/103" 0.985355265247027 1 0 0 0.331639209703763 0.00489268236760034 "NDUFS1;SLC25A14"
"369" "Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341" "1/71" 0.986312947133421 1 0 0 0.240555201404842 0.00331523174736815 "SP1"
